<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Illumina, Inc.

    Illumina, Inc.

    A global leader in DNA sequencing and array-based technologies, Illumina is fuelin...

    A global leader in DNA sequencing and array-bas...

    Filing Type:    PU
    Alseres Pharmaceuticals

    Alseres Pharmaceuticals

    Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and ther...

    Alseres Pharmaceuticals, Inc. is focused on the...

    Amount Raised:    $5,900,000
    Fundraising Status:    VT
    Filing Type:    PU
    Bioclonetics Immunotherapeutics, Inc.

    Bioclonetics Immunotherapeutics, Inc.

    BioClonetics Immunotherapeutics is a biotechnology company with a proprietary meth...

    BioClonetics Immunotherapeutics is a biotechnol...

    Amount Raised:    $255,600
    Fundraising Status:    EC
    Filing Type:    CF
    YiLoLife Inc

    YiLoLife Inc

    YiLo Life uses organic methods and the finest ingredients to create cannabis produ...

    YiLo Life uses organic methods and the finest i...

    Fundraising Status:    EC
    Filing Type:    RA
    Replimune Group, Inc.

    Replimune Group, Inc.

    Cancer is one of the most difficult diseases to treat. It is constantly changing, ...

    Cancer is one of the most difficult diseases to...

    Filing Type:    PU
    Phibro Animal Health Corporation

    Phibro Animal Health Corporation

    Phibro Animal Health Corporation is a leading global diversified animal health and...

    Phibro Animal Health Corporation is a leading g...

    Filing Type:    PU
    Incyte Corporation

    Incyte Corporation

    Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focus...

    Incyte Corporation is a Wilmington, Delaware-ba...

    Filing Type:    PU
    Nemucore Medical Innovations, Inc.

    Nemucore Medical Innovations, Inc.

    Nemucore Medical Innovations is here to bring you the future of cancer care. Theyâ...

    Nemucore Medical Innovations is here to bring y...

    Amount Raised:    $92,318.00
    Fundraising Status:    EC
    Filing Type:    CF
    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.